Alzheimer’s disease (AD), the most studied tauopathy, features aggregated tau in the form of neurofibrillary tangles (NFTs), linked to prior deposition of amyloid beta protein aggregates, and is thus classified as a secondary tauopathy (Fig. 3) [51]. Here, MAPT is linked to tauopathy.